Literature DB >> 17360658

Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression.

Hideyuki Yanai1, Hui-Min Chen, Takayuki Inuzuka, Seiji Kondo, Tak W Mak, Akinori Takaoka, Kenya Honda, Tadatsugu Taniguchi.   

Abstract

Host defense consists of two main aspects, namely, immune response to invading pathogens and suppression of tumor development. A family of transcription factors, IFN regulatory factors (IRFs), has recently gained much attention in terms of its critical role in linking these two aspects of host defense, wherein IRF5 was previously shown to play a critical role in the induction of proinflammatory cytokines by activation of Toll-like receptors. In the present study, using IRF5 gene-targeted mice (Irf5(-/-) mice), we demonstrate another facet of the IRF5 function in the regulation of immune response and tumor suppression. We show that IRF5 is critical for antiviral immunity by showing that Irf5(-/-) mice are highly vulnerable to viral infections, accompanied by a decrease in type I IFN induction in the sera. Furthermore, we show that Irf5(-/-) fibroblasts are resistant to apoptosis upon viral infection, resulting in an enhanced viral propagation. Finally, we provide evidence that IRF5 is critical for the induction of apoptosis, but not in cell cycle arrest, in response to DNA damage and that IRF5 functions as a tumor suppressor by acting on a pathway that may be distinct from that for p53. These results, together with the dual regulation of IRF5 gene expression by IFN signaling and p53, may provide a new link in the transcriptional network underlying antiviral immunity and tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360658      PMCID: PMC1805533          DOI: 10.1073/pnas.0611559104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

Authors:  E Oda; R Ohki; H Murasawa; J Nemoto; T Shibue; T Yamashita; T Tokino; T Taniguchi; N Tanaka
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

2.  Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection.

Authors:  Tsu-Fan Cheng; Sabrina Brzostek; Osamu Ando; Sarah Van Scoy; K Prasanna Kumar; Nancy C Reich
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.

Authors:  Annett Schoenemeyer; Betsy J Barnes; Margo E Mancl; Eicke Latz; Nadege Goutagny; Paula M Pitha; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  J Biol Chem       Date:  2005-01-28       Impact factor: 5.157

Review 4.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

5.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

6.  IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity.

Authors:  Tomohiko Tamura; Prafullakumar Tailor; Kunihiro Yamaoka; Hee Jeong Kong; Hideki Tsujimura; John J O'Shea; Harinder Singh; Keiko Ozato
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

Review 7.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

8.  IRF-7 is the master regulator of type-I interferon-dependent immune responses.

Authors:  Kenya Honda; Hideyuki Yanai; Hideo Negishi; Masataka Asagiri; Mitsuharu Sato; Tatsuaki Mizutani; Naoya Shimada; Yusuke Ohba; Akinori Takaoka; Nobuaki Yoshida; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-03-30       Impact factor: 49.962

9.  Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage.

Authors:  N Tanaka; M Ishihara; M S Lamphier; H Nozawa; T Matsuyama; T W Mak; S Aizawa; T Tokino; M Oren; T Taniguchi
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

10.  Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death.

Authors:  Guodong Hu; Margo E Mancl; Betsy J Barnes
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

View more
  96 in total

Review 1.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

2.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

3.  Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.

Authors:  Peihong Dai; Hua Cao; Taha Merghoub; Francesca Avogadri; Weiyi Wang; Tanvi Parikh; Chee-Mun Fang; Paula M Pitha; Katherine A Fitzgerald; Masmudur M Rahman; Grant McFadden; Xiaoyu Hu; Alan N Houghton; Stewart Shuman; Liang Deng
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 4.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

5.  Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain.

Authors:  Michelle M Arnold; Mario Barro; John T Patton
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

6.  Infection in systemic lupus erythematosus: friend or foe?

Authors:  Lisa Francis; Andras Perl
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

Review 7.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 8.  The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.

Authors:  Wenjie Zhao; Xiaoyang Yue; Kuai Liu; Junfeng Zheng; Runda Huang; Jun Zou; Gabriela Riemekasten; Frank Petersen; Xinhua Yu
Journal:  Rheumatol Int       Date:  2017-04-22       Impact factor: 2.631

9.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

10.  TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.

Authors:  Hiroyasu Konno; Takuya Yamamoto; Kohsuke Yamazaki; Jin Gohda; Taishin Akiyama; Kentaro Semba; Hideo Goto; Atsushi Kato; Toshiaki Yujiri; Takahiko Imai; Yasushi Kawaguchi; Bing Su; Osamu Takeuchi; Shizuo Akira; Yasuko Tsunetsugu-Yokota; Jun-ichiro Inoue
Journal:  PLoS One       Date:  2009-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.